📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-10-12 19:35
0 analysed today
FollowTelegram
0
Today
151,853
All-time analysed
43,533
Positive
6,742
Negative
92,741
Neutral
8,769
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
3 announcements match the current filters (relevance ≥ 5).
Qualitek Labs Issues EGM Corrigendum on Preferential Allotment Shareholding Details
Qualitek Labs Limited issued a corrigendum to its EGM notice for the meeting scheduled on October 16, 2026. The corrigendum amends the explanatory statement regarding proposed allottees and post-preferential issue shareholding patterns. Notably, ace investor Ashish Kacholia is slated to be allotted up to 1,73,200 equity shares, raising his holding from 4.35% (5,06,400 shares) to 5.65% (6,79,600 shares) post-issue. Additionally, promoter entity TIC Services Private Limited is slated to receive 5,20,000 warrants, bringing its post-conversion holding to 56.52% (70,98,375 shares).
Confidence: HIGH
What changedQualitek Labs updated and clarified post-preferential issue shareholding percentages and allottee details in its EGM explanatory statement.
Why it mattersConfirms participation from marquee investor Ashish Kacholia and promoter commitment via warrants, strengthening capital reserves for growth initiatives.
Ashish Kacholia Proposed Allotment: 1,73,200.00 sharesAshish Kacholia Post-Issue Holding: 5.65%TIC Services Warrants to be Allotted: 5,20,000.00TIC Services Post-Warrant Holding: 56.52%EGM Date: October 16, 2026
📅 Short termMarket sentiment may react positively to the clear details showing marquee investor participation and promoter warrant backing ahead of the October 16 EGM.
📈 Long termCapital raised via preferential allotment will support Qualitek Labs' ongoing lab capacity expansion and inorganic integration strategy.
⚠ Risk flags
- Equity dilution for existing public shareholders
- Shareholder approval pending at the upcoming EGM
Key Highlights
Ashish Kacholia proposed allotment of up to 1,73,200 equity shares, expanding holding from 4.35% to 5.65% post-issue
TIC Services Private Limited proposed to receive up to 5,20,000 warrants, leading to a 56.52% post-warrant conversion stake
EGM scheduled to be held on Friday, October 16, 2026 at 12:30 PM via Video Conferencing
Multiple other individual and institutional investors proposed to receive small minority allocations of equity shares
👀 What to Watch
Track the outcome of the October 16, 2026 EGM voting and monitor the final allotment price and total capital raised once disclosed.
Qualitek Labs Calls EGM to Raise Up to ₹20.02 Cr via Preferential Issue at ₹518.55/Share
Qualitek Labs Limited has issued an EGM notice for October 16, 2026, seeking shareholder approval for a preferential equity issue of up to 3,86,000 shares at ₹518.55 each. The proposed issue aggregates to approximately ₹20.02 crore, representing about 13.7% of the company's net worth of ₹146 crore. Notably, marquee investor Ashish Kacholia is slated to be allotted 1,73,200 shares (around 45% of the total issue). E-voting for eligible shareholders will take place between October 13 and October 15, 2026.
Confidence: HIGH
What changedQualitek Labs has convened an EGM to approve a preferential equity issue of up to 3,86,000 shares to strategic investors and promoters.
Why it mattersThe fundraise injects ₹20.02 crore of equity capital (~13.7% of net worth), strengthening the balance sheet and validating the business model with marquee investor participation.
Total fundraise amount: ₹20,01,60,300Shares to be allotted: 3,86,000Issue price per share: ₹518.55Ashish Kacholia allocation: 1,73,200 sharesFundraise vs Net Worth: ~13.7%
📅 Short termMarket sentiment may be buoyed by high-profile non-promoter participation, with focus on the upcoming EGM voting outcome on October 16, 2026.
📈 Long termAdditional capital provides funding for ongoing expansions across Pune/Noida facilities and recent acquisitions without stressing the current 0.45 D/E ratio.
⚠ Risk flags
- Equity dilution for existing minority shareholders
- Dependency on regulatory/stock exchange listing approvals
Key Highlights
Proposed preferential issue of up to 3,86,000 equity shares aggregating up to ₹20,01,60,300
Issue price set at ₹518.55 per share (including a premium of ₹508.55 per share)
Ace investor Ashish Kacholia proposed to receive 1,73,200 equity shares
EGM scheduled for October 16, 2026, with cut-off date on October 09, 2026 and e-voting ending October 15, 2026
Relevant date for ICDR pricing calculation determined as September 16, 2026
👀 What to Watch
Track shareholder approval at the EGM on October 16, 2026, and subsequent receipt of regulatory listing approvals for the newly issued equity shares.
Qualitek Labs to Raise ₹46.98 Cr via Preferential Shares & Warrants at ₹518.55/Share
Qualitek Labs has approved a total fundraise of up to ₹46.98 crore via preferential allotment of equity shares and convertible warrants at an issue price of ₹518.55 each. The equity issuance comprises up to 3,86,000 shares aggregating ₹20.02 crore, with marquee investor Ashish Kacholia taking 1,73,200 shares. Additionally, 5,20,000 convertible warrants worth ₹26.96 crore will be issued to promoter entity TIC Services Private Limited. An Extra-Ordinary General Meeting (EGM) is scheduled for October 16, 2026, to seek shareholder approval.
Confidence: HIGH
What changedThe board approved a preferential issue of equity and warrants to raise ₹46.98 crore from promoters and non-promoter marquee investors.
Why it mattersThe capital injection will strengthen the balance sheet by adding equity equal to nearly one-third of net worth, potentially funding ongoing expansions in mineral testing and lab footprint.
Total fundraise: ₹46.98 CrIssue price per share/warrant: ₹518.55Equity issue amount: ₹20,01,60,300Warrants issue amount: ₹26,96,46,000Fundraise vs Net Worth: ~32.2%
📅 Short termPositive sentiment driven by backing from prominent investor Ashish Kacholia and promoter commitment through warrants at ₹518.55 (close to the prevailing market price of ₹571).
📈 Long termEnhances capitalization to execute growth plans in food, pharma, and mineral testing, while dilution will expand the equity base by up to 9,06,000 shares upon full warrant conversion.
⚠ Risk flags
- Equity dilution from up to 9.06 lakh new shares
- Shareholder and regulatory approvals required
- Warrant conversion spans up to 18 months, leaving 75% promoter warrant funding subject to future exercise
Key Highlights
Approved issuance of up to 3,86,000 equity shares at ₹518.55 per share, raising ₹20.02 crore
Approved issuance of up to 5,20,000 fully convertible warrants at ₹518.55 per warrant to promoter entity TIC Services Pvt Ltd, raising ₹26.96 crore
Marquee investor Ashish Kacholia proposed to receive 1,73,200 equity shares (around 45% of the equity tranche)
Total capital raise represents ~32% of existing net worth (₹146 crore)
EGM convened for October 16, 2026, to secure shareholder approval
👀 What to Watch
Track shareholder voting results from the EGM on October 16, 2026, and look for disclosures regarding specific deployment of the ₹46.98 crore proceeds across lab expansions or debt repayment.
